Overview
Michele Spencer-Manzon is a Medical Genetics provider in New Haven, Connecticut. Dr. Spencer-Manzon has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in the treatment of Glycogen Storage Disease Type 13. Her top areas of expertise are Tyrosinemia Type 1, Tyrosinemia Type 2, Tyrosinemia Type 3, and Maple Syrup Urine Disease. Dr. Spencer-Manzon is currently accepting new patients.
Her clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Piedmont
Locations
1 Long Wharf Dr, Suite 503, New Haven, CT 06511
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Advanced
- Beta-Ketothiolase Deficiency
- Dihydropteridine Reductase Deficiency
- Fetal Akinesia Sequence
- Maple Syrup Urine Disease
- Maternal Hyperphenylalaninemia
- Methylmalonic Acidemia
- Experienced
- Andersen Disease
- Arthrogryposis Multiplex Congenita
- Congenital Contractures
- Cortical Dysplasia
- Glycogen Storage Disease Type 0
- Glycogen Storage Disease Type 13